Biochemical diagnosis of ventricular dysfunction in elderly patients in general practice: observational study
- 1 April 2000
- Vol. 320 (7239) , 906-908
- https://doi.org/10.1136/bmj.320.7239.906
Abstract
Objective: To investigate the usefulness of measuring plasma concentrations of B type natriuretic peptide in the diagnosis of left ventricular systolic dysfunction in an unselected group of elderly people. Design: Observational study. Setting: General practice with four centres in Poole, Dorset. Participants: 155 elderly patients aged 70 to 84 years. Main outcome measures: Diagnostic characteristics of plasma B type natriuretic peptide measured by radioimmunoassay as a test for left ventricular systolic dysfunction assessed by echocardiography. Results: The median plasma concentration of B type natriuretic peptide was 39.3 pmol/l in patients with left ventricular systolic dysfunction and 15.8 pmol/l in those with normal function. The proportional area under the receiver operator curve was 0.85. At a cut-off point of 18.7 pmol/l the test sensitivity was 92% and the predictive value 18%. Conclusions: Plasma concentration of B type natriuretic peptide could be used effectively as an initial test in a community screening programme and, possibly, using a low cut-off point, as a means of ruling out left ventricular systolic dysfunction. It is, however, not a good test to “rule in” the diagnosis, and access to echocardiography remains essential for general practitioners to diagnose heart failure early.Keywords
This publication has 8 references indexed in Scilit:
- Prevalence and clinical characteristics of left ventricular dysfunction among elderly patients in general practice setting: cross sectional surveyBMJ, 1999
- Biochemical detection of systolic dysfunctionThe Lancet, 1998
- Biochemical detection of left-ventricular systolic dysfunctionThe Lancet, 1998
- Value of natriuretic peptides in assessment of patients with possible new heart failure in primary careThe Lancet, 1997
- N-terminal proatrial natriuretic peptide and brain natriuretic peptide are stable for up to 6 hours in whole blood in vitro.1995
- Fortnightly Review: Ten years of natriuretic peptide research: a new dawn for their diagnostic and therapeutic use?BMJ, 1994
- Validity of clinical diagnosis of heart failure in primary health careEuropean Heart Journal, 1991
- A new natriuretic peptide in porcine brainNature, 1988